skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
TARP 29-37-9V Peptide Vaccine (Code C85463)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: TARP 29-37-9V Peptide Vaccine

Definition: A peptide-based cancer vaccine, consisting of amino acid residues 29 through 37 of T cell receptor gamma alternate reading frame protein (TARP) with a leucine-to-valine substitution at position 9, with potential immunostimulatory and antineoplastic activities. Upon administration, TARP 29-37-9V peptide vaccine may induce a cytotoxic T-lymphocyte (CTL) response against TARP-expressing tumor cells, which may result in decreased tumor cell proliferation. The leucine-to-valine substitution at position 9 of this peptide improves its immunogenicity. The nuclear protein TARP is commonly expressed on prostate and breast cancer cells and is highly immunogenic.

Label: TARP 29-37-9V Peptide Vaccine

NCI Thesaurus Code: C85463 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL412335  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
TARP 29-37-9V Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 643628
PDQ Open Trial Search ID 643628 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C85463
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom